Research Scientist, Fermentation RTD UK - United Kingdom
We are seeking a highly motivated research scientist to join the Molecular Biology and Fermentation department within the Research and Technical Development (RTD) team in Nottingham, UK. You will be expected to work within a team of scientists engaged in multiple projects, producing and characterizing recombinant albumin and associated molecules to support internal and external studies.
You will be responsible for performing and developing fermentation procedures using our Saccharomyces expression system, suitable for RTD and Manufacturing, documenting, interpreting and communicating both internally, and potentially externally, data generated and recommending future actions and initiating new research efforts under supervisory direction.
- Recent PhD or BSc with at least 3 years’ experience in a relevant setting
- cGLP and cGMP awareness is useful
- Good theoretical and practical knowledge of microbial physiology and fermentation with evidence of system biology and DoE understanding.
- Ability to work independently to deadlines, be flexible to changing priorities and be comfortable multitasking
- Good communication and presentation skills and in depth knowledge of research area
The successful candidate will work as part of a fast moving multi-disciplinary RTD team that has close interaction with a broad range of other departments. The candidate will work closely with other members of the Molecular Biology and Fermentation department and the Bioprocess Characterisation Department within RTD. They are also likely to liaise with other departments such as Clinical Development, Marketing and Commercial. In addition to working to deadlines the candidate must be flexible to changing priorities, be comfortable multitasking and be a team player with good communication and scientific writing skills.
Albumedix helps biopharmaceutical companies improve patient outcomes with a range of albumin-based products and technologies that facilitate the development of superior biotherapeutics.
Albumedix develops albumin-based products and technologies for advanced drug and vaccine formulation, extended drug half-life and improved drug delivery. Our products and technologies are used in clinical and marketed drugs and out-licensed to pharmaceutical and biotech companies worldwide. With over 25 years’ experience in the biopharmaceutical industry, we have the scientific, technical and regulatory expertise needed to support companies in moving faster to market with superior biotherapeutics. We also use this expertise to strengthen our own drug pipeline. Albumedix is a global company and a fully owned subsidiary of Novozymes.